Comparison of pharmacodynamic target attainment between healthy subjects and patients for ceftazidime and meropenem.
Kuti, Joseph L
Comparison of pharmacodynamic target attainment between healthy subjects and patients for ceftazidime and meropenem. [electronic resource] - Pharmacotherapy Jul 2005 - 935-41 p. digital
Publication Type: Comparative Study; Journal Article
0277-0008
10.1592/phco.2005.25.7.935 doi
Acinetobacter baumannii--drug effects
Anti-Bacterial Agents--pharmacokinetics
Ceftazidime--pharmacokinetics
Clinical Trials as Topic
Drug Resistance, Bacterial
Escherichia coli--drug effects
Female
Gram-Negative Bacterial Infections--drug therapy
Half-Life
Humans
Klebsiella pneumoniae--drug effects
Male
Meropenem
Microbial Sensitivity Tests
Monte Carlo Method
North America
Pseudomonas aeruginosa--drug effects
Reference Values
South America
Thienamycins--pharmacokinetics
Comparison of pharmacodynamic target attainment between healthy subjects and patients for ceftazidime and meropenem. [electronic resource] - Pharmacotherapy Jul 2005 - 935-41 p. digital
Publication Type: Comparative Study; Journal Article
0277-0008
10.1592/phco.2005.25.7.935 doi
Acinetobacter baumannii--drug effects
Anti-Bacterial Agents--pharmacokinetics
Ceftazidime--pharmacokinetics
Clinical Trials as Topic
Drug Resistance, Bacterial
Escherichia coli--drug effects
Female
Gram-Negative Bacterial Infections--drug therapy
Half-Life
Humans
Klebsiella pneumoniae--drug effects
Male
Meropenem
Microbial Sensitivity Tests
Monte Carlo Method
North America
Pseudomonas aeruginosa--drug effects
Reference Values
South America
Thienamycins--pharmacokinetics